A Comparative Study to Evaluate the Effect of Ayurvedic Leech Therapy and Modern Serratiopeptidase in Reducing Inflammation in patients with Cellulitis ageing from 18-60 years

A randomized controlled trial of Jalaukavacharana in comparison with Serratiopeptidase in reducing inflammatory markers in Vranashopha w.s.r. Cellulitis - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105968

Enrollment

Registered

2026-03-11

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L039- Cellulitis and acute lymphangitis,unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed case of Amavastha and Pachyamana avastha of Vranashopha. Patient of age group between 18 - 60 years. Patient fit for Raktamokshana

Exclusion criteria

Exclusion criteria: Pakwavastha of Vranashopha Uncontrolled systemic diseases such as HTN, DM etc. Immuno-compromised patients. Severe anemia. Septicemia.

Design outcomes

Primary

Measure	Time frame
It may show reduction in inflammatory marker( CRP, ESR, TLC ) in the patient of cellulitis treated with jalaukavacharan.Timepoint: At the end of 14 days (1, 7, 14 days)	—

Secondary

Measure	Time frame
It may show therapeutic effect of Jalaukavacharana in reducing the signs and symptoms of inflammation in the both group in Calor (heat) Dolor (pain) Tumor (swelling) Rubor (redness) in patients presenting with Vranashopha (cellulitis). It shows the efficacy of both the treatment in patient of cellulitis.Timepoint: At the end of 14 days (1, 7, 14 days)	—

Countries

India

Contacts

Public ContactDr Poonam Shamrao Malave

Shri Ayurved Mahavidyalaya, Nagpur

drsandesh1128@gmail.com9987014379

Outcome results